Podcast: Flexion's CEO Mike Clayman on Targeting Key Therapeutic Areas as a Business Strategy - - BioPharm International

ADVERTISEMENT

Podcast: Flexion's CEO Mike Clayman on Targeting Key Therapeutic Areas as a Business Strategy


blog comments powered by Disqus


Angie Drakulich, Editorial Director of BioPharm International, talks with Mike Clayman, CEO of Flexion Therapeutics. Based in Woburn, MA, the company works to develop therapeutics for musculoskeletal disorders. In this podcast, Clayman discusses why the company chose to focus on a full range of treatments for one particular disease, osteoarthritis, and how the approach has helped the company fill its biopharmaceutical pipeline and market space. Posted Apr. 2012.

ADVERTISEMENT

ADVERTISEMENT

Suppliers Seek to Boost Single-Use Technology
August 21, 2014
Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen
August 20, 2014
USP Center in Ghana Receives International Lab Accreditation
August 15, 2014
USP Awards Analytical Research
August 15, 2014
FDA Warns about Fraudulent Ebola Treatments
August 15, 2014
Author Guidelines

Click here